response to deoxycoformycin in t cell leukaemias [letter]

NLM AIDSLINE Response to deoxycoformycin in T cell leukaemias [letter] Catovsky D; Dearden C
June 30, 1988

Br Med J (Clin Res Ed). 1988 Jan 30;296(6618):356. Unique Identifier : Antineoplastic Agents/THERAPEUTIC USE Coformycin/ANALOGS & DERIVATIVES/THERAPEUTIC USE Human HTLV-BLV Infections/DRUG THERAPY Ribonucleosides/THERAPEUTIC USE LETTER JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 SWITZERLAND: Swiss TB Rate Below European Average SOUTH CAROLINA: DHEC Orders North Charleston Clinic to Halt Invasive Procedures CANADA: New Facility Unveiled for Homeless With Hepatitis C FLORIDA: Gospel of Health: Block Party Promotes HIV and AIDS Awareness CALIFORNIA: 2Cents Theatre Group Announces Plans to Benefit HIV/AIDS Organizations with RENT UNITED STATES: HCV Prevalence Higher Among Asian-Americans WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM MICHIGAN: Michigan Department of Community Health Encourages Testing for America's Silent Epidemic: Viral Hepatitis Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name? General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events AHF: Obama’s Response to AIDS Criticized in New “It's a Shame” Ads Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat World Health Organization launches emergency response to antimalarial drug resistance Australia ups leadership role in the global AIDS response CONCACAF and UNAIDS team up to engage football in the response to AIDS US Congress and leading actors in the global AIDS response discuss shared responsibility in creating an AIDS-free generation BELGIUM: Long-Term Suppression of Viral Load and Sustained CD4 Cell Increase Reduce Risk of Cervical HPV Infection for HIV-Positive Women
Information in this article was accurate in June 30, 1988. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.